ARX vs TECH · rev $912.9M vs P/E 65, rev $1.22B
Accelerant Holdings (ARX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Accelerant Holdings (ARX) is a insurance brokers company listed on NYSE.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported ARX revenue for 2025-12-31 was $912.9M. Net income was -$1.35B. Revenue was up 51.5% from 2024-12-31 to 2025-12-31. ARX currently screens at market cap $2.84B.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
ARX currently screens at market cap $2.84B. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the ARX and TECH stock pages for the full models.
Not investment advice.